Diabetes news and diabetes widget
Friday, October 17, 2008 ( change date )
Diabetes And Vision Impairment
A study published in the Archives of Ophthalmology finds that people with diabetes are more likely to have visual impairment than people without the disease. Diabetes mellitus - the metabolic syndrome characterized by the body's inability to regulate blood sugar levels - was known to afflict about 14.6 million Americans in 2005, and an additional 6.2 million suffered from the disease but remained undiagnosed. By 2050, public health experts expect that some 48.
Medicalnewstoday.com Friday, October 17, 2008The Wyeth Symposium On Metabolic Dysregulation Presented By Boston University
Boston University Department of Pharmacology and Experimental Therapeutics will present the "Wyeth Symposium on Metabolic Dysregulation" on October 22nd at the Boston University Trustees Ballroom, One Sherborn Street, Boston, Mass. The free event (8:30 a.m.- 5:00 p.m.
Medicalnewstoday.com Friday, October 17, 2008Aspirin no heart protection for diabetics: study (Reuters)
Reuters - Doctors should not routinely give aspirin to people with diabetes to help guard against a heart attack or stroke, a British study found on Friday.
yahoo.com Friday, October 17, 2008Fructose Hampers Hormone That Controls Appetite, UF Study Finds
Could all those years chewing candy and slurping sugary sodas come back to haunt you? Perhaps. A new University of Florida study in rats shows that a fructose-filled diet blocks the appetite-controlling hormone leptin from doing its job, setting the body up for future obesity. Leptin is critical in controlling appetite and energy expenditure, and scientists have long linked leptin resistance to obesity.
Medicalnewstoday.com Friday, October 17, 2008New Data From Head-to-head Phase 3 Trial Demonstrate That Liraglutide Is More Effective Than Exenatide In Treatment Of Type 2 Diabetes
Today, at the Canadian diabetes Association Congress, physicians will get a first-time look at more detailed results from a phase 3b clinical study (LEADT 6) comparing the investigational new drug liraglutide to exenatide. The study showed that liraglutide, a human GLP-1 analogue administered once daily, was significantly more effective at improving glycaemic control (as measured by HbA1c) than exenatide, a GLP-1 mimetic administered twice daily.
Medicalnewstoday.com Friday, October 17, 2008Amniocentesis
Title: AmniocentesisCategory: Procedures and TestsCreated: 12/31/1997Last Editorial review: 10/17/2008
MedicineNet Friday, October 17, 2008Aspirin Doesn't Prevent First Heart Attack, Stroke
Title: Aspirin Doesn't Prevent First Heart Attack, StrokeCategory: health newscreated: 10/17/2008 2:00:00 amlast Editorial review: 10/17/2008
MedicineNet Friday, October 17, 2008Presidential Debate: Joe the Plumber and Health Care
Title: Presidential Debate: Joe the Plumber and health CareCategory: health newscreated: 10/17/2008Last Editorial review: 10/17/2008
MedicineNet Friday, October 17, 2008
PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET